Davis Schneider described his late brother Steven as a real-life Superman, a dedicated nurse who selflessly helped others until his tragic death from an opioid overdose in November 2020. Steven, just 26 years old, was found alone in a room in a New Jersey home during a challenging period marked by the COVID-19 pandemic. Davis expressed regret for not recognizing his brother’s struggles earlier, emphasizing the importance of naloxone, a life-saving drug that could have potentially saved Steven’s life if administered in time.
Motivated by his personal loss, Davis accepted an offer from Emergent BioSolutions, the manufacturer of Narcan nasal spray, to raise awareness about opioid overdoses and naloxone. The partnership was made public on Wednesday, highlighting the alarming statistics of over 55,000 deaths due to opioid poisoning in Canada between January 2016 and September 2025.
Despite the availability of free naloxone kits across the country, many individuals fail to access them, leading to preventable deaths. Dr. Taryn Lloyd, an emergency department physician, emphasized the importance of naloxone in reversing opioid overdoses, underscoring its effectiveness in saving lives when administered promptly. She encouraged the public to carry naloxone kits for emergencies, as it can be crucial in preventing tragic outcomes.
Davis advocates for widespread access to naloxone kits, envisioning them as readily available as fire extinguishers in public spaces. Experts like Tim Deloughery from the Canadian Centre on Substance Use and Addiction affirm that naloxone is a life-saving intervention, emphasizing the need for its immediate availability during emergencies. Davis fondly remembers his brother Steven, regretting that he couldn’t witness his achievements in Major League Baseball and the camaraderie with his Blue Jays teammates, reflecting on the profound impact of his brother’s absence.